Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ALPHARETTA, Ga., July 15, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that pre-clinical results using the Company’s patented Pulsed Acoustic Cellular Expression (PACE®) technology, which uses focused high-energy acoustic shock waves, were presented by Dr. Maria Siemionow in an oral presentation at the 2013 World Congress of Microsurgery. The results showed that the application of dermaPACE® appears to substantially decrease the inflammation and tissue damage that typically occurs when blood flow is interrupted during microsurgical procedures.
Help employers find you! Check out all the jobs and post your resume.